• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫酸吲哚酚作为肾功能不全时心房颤动诱发因素的作用

Role of Indoxyl Sulfate as a Predisposing Factor for Atrial Fibrillation in Renal Dysfunction.

作者信息

Aoki Kohei, Teshima Yasushi, Kondo Hidekazu, Saito Shotaro, Fukui Akira, Fukunaga Naoya, Nawata Tomoko, Shimada Tatsuo, Takahashi Naohiko, Shibata Hirotaka

机构信息

Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Oita University Faculty of Medicine, Oita, Japan (K.A., N.F., T.N., H.S.).

Department of Cardiology and Clinical Examination, Oita University Faculty of Medicine, Oita, Japan (Y.T., H.K., S.S., A.F., N.T.).

出版信息

J Am Heart Assoc. 2015 Oct 9;4(10):e002023. doi: 10.1161/JAHA.115.002023.

DOI:10.1161/JAHA.115.002023
PMID:26452986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4845145/
Abstract

BACKGROUND

Renal dysfunction is a major risk factor for atrial fibrillation (AF). The uremic toxin indoxyl sulfate may contribute to the progression of cardiac fibrosis and AF substrate in renal dysfunction.

METHODS AND RESULTS

Male Sprague-Dawley rats were assigned randomly to the following groups: 5/6 nephrectomy (5/6Nx) with vehicle, 5/6Nx with AST-120, sham procedure with vehicle, and sham procedure with AST-120. Vehicle and AST-120 were administered for 4 weeks. Serum levels of IS were significantly increased in 5/6Nx groups. Expression of malondialdehyde, an indicator of oxidative stress, was upregulated in the left atrium of 5/6Nx groups and was accompanied by an increase in expression of NADPH oxidase 2 and 4. Monocyte-mediated inflammatory signals such as CD68, monocyte chemoattractant protein 1, and vascular cell adhesion molecule 1 were also upregulated in 5/6Nx groups. Interstitial fibrosis was promoted heterogeneously, and expression of profibrotic indicators such as transforming growth factor β1, α-smooth muscle actin, and collagen type 1 was upregulated in left atrium tissue of 5/6Nx groups. In cultured atrial fibroblasts, incubation with IS upregulated expression of the markers of oxidative stress, inflammation, and profibrotic factors. These results suggest the direct effects of IS on the progression of AF substrate. AF was consistently and invariably induced by atrial extrastimuli in 5/6Nx groups in electrophysiological experiments. AST-120 treatment significantly alleviated renal dysfunction-induced oxidative stress, inflammation, and atrial fibrosis and, consequently, attenuated AF inducibility.

CONCLUSIONS

Indoxyl sulfate facilitates atrial fibrosis and AF and thus is a novel therapeutic target for prevention of renal dysfunction-induced AF.

摘要

背景

肾功能不全是心房颤动(AF)的主要危险因素。尿毒症毒素硫酸吲哚酚可能促进肾功能不全时心脏纤维化及AF基质的进展。

方法与结果

将雄性Sprague-Dawley大鼠随机分为以下几组:假手术组(给予赋形剂)、假手术组(给予AST-120)、5/6肾切除组(给予赋形剂)、5/6肾切除组(给予AST-120)。赋形剂和AST-120给药4周。5/6肾切除组血清硫酸吲哚酚水平显著升高。氧化应激指标丙二醛的表达在5/6肾切除组左心房上调,并伴有NADPH氧化酶2和4表达增加。5/6肾切除组中单核细胞介导的炎症信号如CD68、单核细胞趋化蛋白1和血管细胞黏附分子1也上调。间质纤维化呈异质性促进,5/6肾切除组左心房组织中促纤维化指标如转化生长因子β1、α平滑肌肌动蛋白和I型胶原的表达上调。在培养的心房成纤维细胞中,硫酸吲哚酚孵育上调氧化应激、炎症和促纤维化因子标志物的表达。这些结果提示硫酸吲哚酚对AF基质进展有直接作用。在电生理实验中,5/6肾切除组心房额外刺激始终能诱发AF。AST-120治疗显著减轻肾功能不全诱导的氧化应激、炎症和心房纤维化,从而减弱AF的诱发率。

结论

硫酸吲哚酚促进心房纤维化和AF,因此是预防肾功能不全诱导AF的新治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/6ff399416685/JAH3-4-e002023-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/e152d06abe39/JAH3-4-e002023-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/e5eec2230fbe/JAH3-4-e002023-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/2bad94cc4013/JAH3-4-e002023-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/91505f1140b9/JAH3-4-e002023-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/334e302f0743/JAH3-4-e002023-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/8c5270441260/JAH3-4-e002023-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/78246237db51/JAH3-4-e002023-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/0a089210139a/JAH3-4-e002023-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/56c49c88b56e/JAH3-4-e002023-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/3834336226b3/JAH3-4-e002023-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/6ff399416685/JAH3-4-e002023-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/e152d06abe39/JAH3-4-e002023-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/e5eec2230fbe/JAH3-4-e002023-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/2bad94cc4013/JAH3-4-e002023-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/91505f1140b9/JAH3-4-e002023-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/334e302f0743/JAH3-4-e002023-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/8c5270441260/JAH3-4-e002023-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/78246237db51/JAH3-4-e002023-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/0a089210139a/JAH3-4-e002023-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/56c49c88b56e/JAH3-4-e002023-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/3834336226b3/JAH3-4-e002023-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9326/4845145/6ff399416685/JAH3-4-e002023-g012.jpg

相似文献

1
Role of Indoxyl Sulfate as a Predisposing Factor for Atrial Fibrillation in Renal Dysfunction.硫酸吲哚酚作为肾功能不全时心房颤动诱发因素的作用
J Am Heart Assoc. 2015 Oct 9;4(10):e002023. doi: 10.1161/JAHA.115.002023.
2
Establishment of a model of atrial fibrillation associated with chronic kidney disease in rats and the role of oxidative stress.建立大鼠心房颤动伴慢性肾脏病模型及氧化应激的作用。
Heart Rhythm. 2012 Dec;9(12):2023-31. doi: 10.1016/j.hrthm.2012.08.019. Epub 2012 Aug 17.
3
An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys.一种口服吸附剂可减轻尿毒症大鼠肾脏中硫酸吲哚酚的负荷及转化生长因子β1的基因表达。
Nephrol Dial Transplant. 2000 Nov;15(11):1773-81. doi: 10.1093/ndt/15.11.1773.
4
Stat3 contributes to indoxyl sulfate-induced inflammatory and fibrotic gene expression and cellular senescence.Stat3 有助于吲哚硫酸酯诱导的炎症和纤维化基因表达及细胞衰老。
Am J Nephrol. 2012;36(2):184-9. doi: 10.1159/000341515. Epub 2012 Aug 8.
5
Indoxyl sulfate suppresses endothelial progenitor cell-mediated neovascularization.硫酸吲哚酚抑制内皮祖细胞介导的新生血管形成。
Kidney Int. 2016 Mar;89(3):574-85. doi: 10.1016/j.kint.2015.11.020. Epub 2016 Jan 21.
6
Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.硫酸吲哚酚在慢性肾脏病和心血管疾病进展中的作用:口服吸附剂AST-120的实验和临床效果
Ther Apher Dial. 2011 Apr;15(2):120-4. doi: 10.1111/j.1744-9987.2010.00882.x. Epub 2011 Jan 25.
7
Uremia induces abnormal oxygen consumption in tubules and aggravates chronic hypoxia of the kidney via oxidative stress.尿毒症通过氧化应激引起肾小管异常耗氧,并加重肾脏慢性缺氧。
Am J Physiol Renal Physiol. 2010 Aug;299(2):F380-6. doi: 10.1152/ajprenal.00175.2010. Epub 2010 Jun 2.
8
Rhubarb Enema Attenuates Renal Tubulointerstitial Fibrosis in 5/6 Nephrectomized Rats by Alleviating Indoxyl Sulfate Overload.大黄灌肠通过减轻硫酸吲哚酚过载减轻5/6肾切除大鼠的肾小管间质纤维化。
PLoS One. 2015 Dec 15;10(12):e0144726. doi: 10.1371/journal.pone.0144726. eCollection 2015.
9
Uremic Toxins and Atrial Fibrillation: Mechanisms and Therapeutic Implications.尿毒症毒素与心房颤动:机制与治疗意义。
Toxins (Basel). 2019 Oct 13;11(10):597. doi: 10.3390/toxins11100597.
10
Combination therapy with benazepril and oral adsorbent ameliorates progressive renal fibrosis in uremic rats.贝那普利与口服吸附剂联合治疗可改善尿毒症大鼠的进行性肾纤维化。
Nephron. 2002 Mar;90(3):297-312. doi: 10.1159/000049066.

引用本文的文献

1
Contribution of NLRP3-GSDMD axis to PDGF-BB-induced vascular smooth muscle cell phenotypic transition.NLRP3-GSDMD轴对血小板衍生生长因子-BB诱导的血管平滑肌细胞表型转变的作用
Am J Physiol Cell Physiol. 2025 Aug 1;329(2):C682-C698. doi: 10.1152/ajpcell.00226.2025. Epub 2025 Jul 21.
2
Impact of gut microbiome on atrial fibrillation: Mechanistic insights and future directions in individualized medicine.肠道微生物群对心房颤动的影响:个性化医学的机制见解与未来方向
World J Cardiol. 2025 Jun 26;17(6):107386. doi: 10.4330/wjc.v17.i6.107386.
3
The gut-heart axis: unveiling the roles of gut microbiota in cardiovascular diseases.

本文引用的文献

1
The uremic toxin indoxyl sulfate increases pulmonary vein and atrial arrhythmogenesis.尿毒症毒素硫酸吲哚酚会增加肺静脉和心房心律失常的发生。
J Cardiovasc Electrophysiol. 2015 Feb;26(2):203-10. doi: 10.1111/jce.12554. Epub 2014 Nov 4.
2
Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats.血糖波动增加糖尿病大鼠心房颤动的发生率。
Cardiovasc Res. 2014 Oct 1;104(1):5-14. doi: 10.1093/cvr/cvu176. Epub 2014 Jul 31.
3
Oxidized Ca(2+)/calmodulin-dependent protein kinase II triggers atrial fibrillation.
肠-心轴:揭示肠道微生物群在心血管疾病中的作用
Front Cardiovasc Med. 2025 May 26;12:1572948. doi: 10.3389/fcvm.2025.1572948. eCollection 2025.
4
Benefits and Pitfalls of Uraemic Toxin Measurement in Peritoneal Dialysis.腹膜透析中尿毒症毒素测量的益处与陷阱
J Clin Med. 2025 Feb 19;14(4):1395. doi: 10.3390/jcm14041395.
5
Indoxyl Sulfate and Its Potential Role in Mineralocorticoid Receptor Transactivation in Chronic Kidney Disease.硫酸吲哚酚及其在慢性肾脏病盐皮质激素受体反式激活中的潜在作用。
Cureus. 2024 Dec 6;16(12):e75236. doi: 10.7759/cureus.75236. eCollection 2024 Dec.
6
The Ability of AST-120 to Lower the Serum Indoxyl Sulfate Level Improves Renal Outcomes and the Lipid Profile in Diabetic and Nondiabetic Animal Models of Chronic Kidney Disease: A Meta-Analysis.AST-120降低血清硫酸吲哚酚水平的能力改善慢性肾脏病糖尿病和非糖尿病动物模型的肾脏结局及脂质谱:一项荟萃分析
Toxins (Basel). 2024 Dec 16;16(12):544. doi: 10.3390/toxins16120544.
7
Gut Microbiota in Patients Receiving Dialysis: A Review.接受透析患者的肠道微生物群:综述
Pathogens. 2024 Sep 15;13(9):801. doi: 10.3390/pathogens13090801.
8
Atrial Fibrillation and Chronic Kidney Disease: Aetiology and Management.心房颤动与慢性肾脏病:病因与管理
Rev Cardiovasc Med. 2024 Apr 9;25(4):143. doi: 10.31083/j.rcm2504143. eCollection 2024 Apr.
9
Costunolide Inhibits Chronic Kidney Disease Development by Attenuating IKKβ/NF-κB Pathway.**标题**:Costunolide 通过抑制 IKKβ/NF-κB 通路抑制慢性肾脏病的发展。
Drug Des Devel Ther. 2024 Jul 2;18:2693-2712. doi: 10.2147/DDDT.S466092. eCollection 2024.
10
Indoxyl sulphate-initiated activation of cardiac fibroblasts is modulated by aryl hydrocarbon receptor and nuclear factor-erythroid-2-related factor 2.对甲酚硫酸盐引发的心肌成纤维细胞激活受芳香烃受体和核因子红细胞 2 相关因子 2 调节。
J Cell Mol Med. 2024 Apr;28(7):e18192. doi: 10.1111/jcmm.18192.
氧化钙(2+)/钙调蛋白依赖性蛋白激酶 II 触发心房颤动。
Circulation. 2013 Oct 15;128(16):1748-57. doi: 10.1161/CIRCULATIONAHA.113.003313. Epub 2013 Sep 12.
4
A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement.抗氧化强化预防术后心房颤动的随机对照试验。
J Am Coll Cardiol. 2013 Oct 15;62(16):1457-65. doi: 10.1016/j.jacc.2013.07.014. Epub 2013 Jul 31.
5
Nicotinamide adenine dinucleotide phosphate oxidase 4 mediates the differential responsiveness of atrial versus ventricular fibroblasts to transforming growth factor-β.烟酰胺腺嘌呤二核苷酸磷酸氧化酶 4 介导电场与室场纤维母细胞对转化生长因子-β反应的差异。
Circ Arrhythm Electrophysiol. 2013 Aug;6(4):790-8. doi: 10.1161/CIRCEP.113.000338. Epub 2013 Jul 24.
6
Oral activated charcoal adsorbent (AST-120) ameliorates chronic kidney disease-induced intestinal epithelial barrier disruption.口服活性炭吸附剂(AST-120)可改善慢性肾脏病引起的肠道上皮屏障破坏。
Am J Nephrol. 2013;37(6):518-25. doi: 10.1159/000351171. Epub 2013 May 15.
7
Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase.氧化应激与心房颤动:NADPH 氧化酶的新作用
J Mol Cell Cardiol. 2013 Sep;62:72-9. doi: 10.1016/j.yjmcc.2013.04.019. Epub 2013 May 2.
8
Role of leptin signaling in the pathogenesis of angiotensin II-mediated atrial fibrosis and fibrillation.瘦素信号在血管紧张素 II 介导的心房纤维化和颤动发病机制中的作用。
Circ Arrhythm Electrophysiol. 2013 Apr;6(2):402-9. doi: 10.1161/CIRCEP.111.000104. Epub 2013 Feb 13.
9
Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease.AST-120 降低硫酸吲哚酚可减轻与慢性肾脏病相关的单核细胞炎症。
J Leukoc Biol. 2013 Jun;93(6):837-45. doi: 10.1189/jlb.0112023. Epub 2013 Jan 29.
10
Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease.成人慢性肾脏病患者的阵发心房颤动与终末期肾病风险。
Circulation. 2013 Feb 5;127(5):569-74. doi: 10.1161/CIRCULATIONAHA.112.123992. Epub 2012 Dec 28.